BioLineRx Regains Nasdaq Compliance
BioLineRx Ltd. (BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq")...
Strong Buy
or
BioLineRx News & Analysis
-
-
BioLineRx Reports Publication of GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide and G-CSF
BioLineRx Ltd. (BLRX) today announced the publication of data from the Company's GENESIS Phase 3 clinical trial in the peer-reviewed journal Nature Medicine. The international GENESIS trial...
-
BioLineRx earnings beat by $0.05, revenue was inline with estimates
Investing.com - BioLineRx (NASDAQ: BLRX) reported fourth quarter EPS of $-0.090, $0.05 better than the analyst estimate of $-0.135. Revenue for the quarter came in at $0.00 versus the...
-
BioLineRx Earnings beat, Revenue Inline In Q3
Investing.com - BioLineRx reported third quarter {{erl-15576||earnings that beat analysts' expectations on Tuesday and revenue that was inline with forecasts. The firm reported earnings...
-
BioLineRx Tops Q3 EPS by 15c
BioLineRx (BLRX) reported Q3 EPS of ($0.01), $0.15 better than the analyst estimate of ($0.16).
-
Pre-Open Movers: Wix Gains on Activist Stake, Take-Two Falls on GTA6 Hack
Pre-Open Stock Movers:Virios Therapeutics, Inc. (Nasdaq: VIRI) 63% LOWER; announced topline results from its FORTRESS (Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression...
-
BioLineRx Earnings miss, Revenue Inline In Q2
Investing.com - BioLineRx reported second quarter {{erl-15576||earnings that missed analysts' expectations on Tuesday and revenue that was inline with forecasts. The firm reported earnings...
-
BioLineRx Tops Q2 EPS by 12c
BioLineRx (BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).
-
BioLineRx Tops Q1 EPS by 13c
BioLineRx (BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).
-
BioLineRx Earnings beat, Revenue Inline In Q1
Investing.com - BioLineRx reported first quarter {{erl-15576||earnings that beat analysts' expectations on Wednesday and revenue that was inline with forecasts. The firm reported earnings...
-
BioLineRx Earnings miss, Revenue Inline In Q3
Investing.com - BioLineRx reported third quarter {{erl-15576||earnings that missed analysts' expectations on Thursday and revenue that was inline with forecasts. The firm reported earnings...
-
BioLineRx Earnings beat, Revenue Inline In Q2
Investing.com - BioLineRx reported second quarter {{erl-15576||earnings that beat analysts' expectations on Wednesday and revenue that was inline with forecasts. The firm reported earnings...
-
BioLineRx Earnings miss, Revenue Inline In Q1
Investing.com - BioLineRx reported first quarter {{erl-15576||earnings that missed analysts' expectations on Wednesday and revenue that was inline with forecasts. The firm reported...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.06%
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Telecoms, Basic Materials and Financials sectors propelled shares higher while losses in the Technology,...
-
BioLineRx Earnings miss, Revenue Inline In Q4
Investing.com - BioLineRx reported fourth quarter {{erl-15576||earnings that missed analysts' expectations on Tuesday and revenue that was inline with forecasts. The firm reported earnings...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.74%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Technology and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.15%
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Technology, Consumer Services and Financials sectors propelled shares higher while losses in the...
-
BioLineRx Earnings beat, Revenue Inline In Q3
Investing.com - BioLineRx reported third quarter {{erl-15576||earnings that beat analysts' expectations on Monday and revenue that was inline with forecasts. The firm reported earnings per...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.59%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Consumer Services, Technology and Consumer Goods sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.17%
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Industrials and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow Jones...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.68%
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Technology, Industrials and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
